{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:53:39Z","timestamp":1787241219616,"version":"build-2736575974"},"reference-count":46,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Food allergies are a growing global health concern, particularly among children, with no widely approved curative treatment beyond strict allergen avoidance. Oral immunotherapy (OIT) has emerged as a promising strategy to induce desensitization, yet its implementation is limited due to high rates of allergic reactions and patient non-compliance. Omalizumab, a monoclonal anti-IgE antibody, has been proposed as an adjunct to OIT to enhance safety and efficacy. Objective: This systematic review and meta-analysis aim to evaluate the efficacy and safety of omalizumab in combination with OIT for IgE-mediated food allergy in children. Methods: A systematic literature search was conducted in PubMed\/MEDLINE and Cochrane Central databases to identify randomized controlled trials (RCTs), controlled clinical trials (CCTs), and observational studies assessing omalizumab as an adjunct to OIT in pediatric food allergy. Studies were evaluated for desensitization rates, immunological changes, adverse events, and quality-of-life improvements. Results: OIT combined with omalizumab led to significantly higher rates of desensitization, allowing patients to tolerate higher doses of allergens in a shorter timeframe compared to OIT alone. Omalizumab was associated with a reduction in adverse reactions, including anaphylaxis, and improved treatment adherence. However, the long-term sustainability of tolerance post-omalizumab discontinuation remains uncertain. Conclusions: Omalizumab facilitates rapid and effective desensitization in pediatric food allergy, enhancing the safety of OIT. Further research is needed to determine optimal treatment duration, long-term outcomes, and cost-effectiveness before widespread clinical adoption.<\/jats:p>","DOI":"10.3390\/ph18030437","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T07:59:54Z","timestamp":1742457594000},"page":"437","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Omalizumab and Oral Immunotherapy in IgE-Mediated Food Allergy in Children: A Systematic Review and a Meta-Analysis"],"prefix":"10.3390","volume":"18","author":[{"given":"Enrico Vito","family":"Buono","sequence":"first","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Giann\u00ec","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Scavone","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7710-6995","authenticated-orcid":false,"given":"Carlo","family":"Caffarelli","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1039\/D3FO05351B","article-title":"The structure and potential allergenicity of peanut allergen monomers after roasting","volume":"15","author":"Zhang","year":"2024","journal-title":"Food Funct."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Loh, W., and Tang, M.L.K. (2018). The Epidemiology of Food Allergy in the Global Context. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15092043"},{"key":"ref_3","first-page":"16","article-title":"Allergy and Asthma: Food Allergies","volume":"472","author":"Mehta","year":"2018","journal-title":"FP Essent."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaci.2013.11.020","article-title":"Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment","volume":"133","author":"Sicherer","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100246","DOI":"10.1016\/j.jacig.2024.100246","article-title":"Epidemiology of Paediatric Italian Food Allergy: Results of the EPIFA study","volume":"3","author":"Nocerino","year":"2024","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaci.2014.12.1912","article-title":"Increasing rate of hospitalizations for food-induced anaphylaxis in Italian children: An analysis of the Italian Ministry of Health database","volume":"135","author":"Nocerino","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-016-0089-8","article-title":"Incidence and risk factors for food hypersensitivity in UK infants: Results from a birth cohort study","volume":"6","author":"Grimshaw","year":"2015","journal-title":"Clin. Transl. Allergy"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13052-022-01277-8","article-title":"Diagnostic therapeutic care pathway for pediatric food allergies and intolerances in Italy: A joint position paper by the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP) and the Italian Society for Pediatric Allergy and Immunology (SIAIP)","volume":"48","author":"Caffarelli","year":"2022","journal-title":"Ital. J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wong, G.W.-K. (2024). Food allergies around the world. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1373110"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.anai.2015.05.006","article-title":"Pediatric emergency department visits and hospitalizations due to food-induced anaphylaxis in Illinois","volume":"115","author":"Dyer","year":"2015","journal-title":"Ann. Allergy, Asthma Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaci.2017.11.003","article-title":"Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management","volume":"141","author":"Sicherer","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nri.2016.111","article-title":"Food allergy: Immune mechanisms, diagnosis and immunotherapy","volume":"16","author":"Yu","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coi.2020.03.014","article-title":"Food allergy: Epidemiology, pathogenesis, diagnosis, prevention, and treatment","volume":"66","author":"Lopes","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.iac.2015.08.002","article-title":"Mechanisms Underlying Induction of Tolerance to Foods","volume":"36","author":"Berin","year":"2016","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jaci.2014.05.042","article-title":"Oral immunotherapy induces IgG antibodies that act through Fc\u03b3RIIb to suppress IgE-mediated hypersensitivity","volume":"134","author":"Burton","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jaci.2015.01.012","article-title":"IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens","volume":"135","author":"Santos","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e20164005","DOI":"10.1542\/peds.2016-4005","article-title":"Guidance on completing a written allergy and anaphylaxis emergency plan","volume":"139","author":"Wang","year":"2017","journal-title":"Pediatrics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/all.13319","article-title":"EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy","volume":"73","author":"Pajno","year":"2018","journal-title":"Allergy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2500\/aap.2021.42.200129","article-title":"Novel diagnostic techniques and therapeutic strategies for IgE-mediated food allergy","volume":"42","author":"Passanisi","year":"2021","journal-title":"Allergy Asthma Proc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/pai.13159","article-title":"Oral immunotherapy in pediatrics","volume":"31","author":"Arasi","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12026-010-8183-9","article-title":"Pioneering immunotherapy for food allergy: Clinical outcomes and modulation of the immune response","volume":"49","author":"Kulis","year":"2011","journal-title":"Immunol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2013.12.1037","article-title":"Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)","volume":"133","author":"Syed","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5414\/ALX02141E","article-title":"Use of biologics in food allergy management","volume":"5","author":"Worm","year":"2021","journal-title":"Allergol. Sel."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1939-4551-7-17","article-title":"New strategies with anti-IgE in allergic diseases","volume":"7","author":"Holgate","year":"2014","journal-title":"World Allergy Organ. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13223-020-00419-z","article-title":"Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy","volume":"16","author":"Langlois","year":"2020","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/cea.13469","article-title":"Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents","volume":"49","author":"Vetander","year":"2019","journal-title":"Clin. Exp. Allergy"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2013.09.046","article-title":"A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients","volume":"132","author":"Schneider","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jaci.2011.04.009","article-title":"Rapid oral desensitization in combination with omalizumab therapy in patients with cow\u2019s milk allergy","volume":"127","author":"Nadeau","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Takahashi, M., Soejima, K., Taniuchi, S., Hatano, Y., Yamanouchi, S., Ishikawa, H., Irahara, M., Sasaki, Y., Kido, H., and Kaneko, K. (2017). Oral immunotherapy combined with omalizumab for high\u2013risk cow\u2019s milk allergy: A randomized controlled trial. Sci. Rep., 7, Erratum in Sci. Rep. 2018, 8, 12812. https:\/\/doi.org\/10.1038\/s41598-018-30919-3.","DOI":"10.1038\/s41598-017-16730-6"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2015.10.005","article-title":"A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow\u2019s milk allergy","volume":"137","author":"Wood","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/iid3.542","article-title":"Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy","volume":"10","author":"Badina","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2468-1253(17)30392-8","article-title":"Anti-IgE treatment with oral immunotherapy in multifood allergic participants: A double-blind, randomised, controlled trial","volume":"3","author":"Andorf","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacig.2022.05.006","article-title":"Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)","volume":"1","author":"Wood","year":"2022","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1710-1492-10-7","article-title":"Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab","volume":"10","author":"Dominguez","year":"2014","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamapediatrics.2013.2376","article-title":"The economic impact of childhood food allergy in the United States","volume":"167","author":"Gupta","year":"2013","journal-title":"JAMA Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2012.11.011","article-title":"Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial","volume":"131","author":"Fleischer","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jaci.2016.08.017","article-title":"Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults","volume":"139","author":"Jones","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2011-0204","article-title":"The prevalence, severity, and distribution of childhood food allergy in the United States","volume":"128","author":"Gupta","year":"2011","journal-title":"Pediatrics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13223-017-0223-8","article-title":"Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab","volume":"13","author":"Andorf","year":"2017","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eclinm.2018.12.006","article-title":"A Phase 2 randomized controlled multisite study using omalizumab-facilitated rapid desensitization to test continued vs discontinued dosing in multi-food allergic individuals","volume":"7","author":"Andorf","year":"2019","journal-title":"eClinicalMedicine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/pai.12259","article-title":"Possible recurrence of symptoms after discontinuation of omalizumab in anti-IgE-assisted desensitization to egg","volume":"25","author":"Lafuente","year":"2014","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2020.08.039","article-title":"Determinants of omalizumab dose\u2013related efficacy in oral immunotherapy: Evidence from a cohort of 181 patients","volume":"147","author":"Azzano","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000442668","article-title":"Influence of omalizumab on allergen-specific IgE in patients with adult asthma","volume":"168","author":"Mizuma","year":"2015","journal-title":"Int. Arch. Allergy Immunol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/3\/437\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:57:04Z","timestamp":1760029024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/3\/437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ph18030437"],"URL":"https:\/\/doi.org\/10.3390\/ph18030437","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]}}}